{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:52:14Z","timestamp":1770987134163,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":6403,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jpain.2005.10.005","type":"journal-article","created":{"date-parts":[[2006,3,3]],"date-time":"2006-03-03T07:34:11Z","timestamp":1141371251000},"page":"187-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neuroleptics Antagonize Nalbuphine Antianalgesia"],"prefix":"10.1016","volume":"7","author":[{"given":"Robert W.","family":"Gear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Miaskowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newton C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon D.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2005.10.005_bib1","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"485","article-title":"Drugs and the treatment of psychiatric disorders","author":"Baldessarini","year":"2001"},{"key":"10.1016\/j.jpain.2005.10.005_bib2","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/0014-2999(93)90650-7","article-title":"Functional antagonism of morphine analgesia by (+)-pentazocine","volume":"250","author":"Chien","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2005.10.005_bib3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-3565(25)24045-9","article-title":"Selective antagonism of opioid analgesia by a sigma system","volume":"271","author":"Chien","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2005.10.005_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/1098-2396(20010315)39:4<323::AID-SYN1016>3.0.CO;2-1","article-title":"Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor","volume":"39","author":"Couture","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.jpain.2005.10.005_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-198326030-00002","article-title":"Nalbuphine","volume":"26","author":"Errick","year":"1983","journal-title":"Drugs"},{"key":"10.1016\/j.jpain.2005.10.005_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0885-3924(94)90175-9","article-title":"Differences in postoperative pain severity among four ethnic groups","volume":"9","author":"Faucett","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2005.10.005_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpain.2004.01.007","article-title":"Sex differences in opioid analgesia","volume":"8","author":"Fillingim","year":"2004","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2005.10.005_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00000542-200405000-00031","article-title":"Experimental pain models reveal no sex differences in pentazocine analgesia in humans","volume":"100","author":"Fillingim","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2005.10.005_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3940(96)12402-2","article-title":"Gender difference in analgesic response to the kappa-opioid pentazocine","volume":"205","author":"Gear","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2005.10.005_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(03)00939-X","article-title":"Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans","volume":"351","author":"Gear","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2005.10.005_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(02)01438-6","article-title":"Sexual dimorphism in very low dose nalbuphine postoperative analgesia","volume":"339","author":"Gear","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2005.10.005_bib12","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm1196-1248","article-title":"Kappa-opioids produce significantly greater analgesia in women than in men","volume":"2","author":"Gear","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jpain.2005.10.005_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(99)00119-0","article-title":"The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain","volume":"83","author":"Gear","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2005.10.005_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1526-5900(00)90097-X","article-title":"Action of naloxone on gender-dependent analgesic and anti-analgesic effects of nalbuphine in humans","volume":"1","author":"Gear","year":"2000","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2005.10.005_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0306-4522(95)00335-G","article-title":"Enhancement of morphine analgesia by the GABAB agonist baclofen","volume":"69","author":"Gordon","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2005.10.005_bib16","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"569","article-title":"Opioid analgesics","author":"Gutstein","year":"2001"},{"key":"10.1016\/j.jpain.2005.10.005_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/312755a0","article-title":"Influence of the method of drug administration on analgesic response","volume":"312","author":"Levine","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jpain.2005.10.005_bib18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI113768","article-title":"Potentiation of pentazocine analgesia by low-dose naloxone","volume":"82","author":"Levine","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpain.2005.10.005_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02246947","article-title":"Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2\u2019-iodospiperone","volume":"110","author":"Leysen","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpain.2005.10.005_bib20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2005.10.005_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(00)00430-1","article-title":"Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions","volume":"401","author":"Matsumoto","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2005.10.005_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/syn.890170307","article-title":"Sigma-1 and sigma-2 sites in rat brain","volume":"17","author":"McCann","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.jpain.2005.10.005_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-6147(92)90030-A","article-title":"A proposal for the classification of sigma binding sites","volume":"13","author":"Quirion","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpain.2005.10.005_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130051061","article-title":"Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors","volume":"145","author":"Takahashi","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpain.2005.10.005_bib25","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1073\/pnas.80.21.6703","article-title":"Naloxone-inaccessible sigma receptor in rat central nervous system","volume":"80","author":"Tam","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2005.10.005_bib26","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.81.17.5618","article-title":"Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes","volume":"81","author":"Tam","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2005.10.005_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0021-5198(19)52463-5","article-title":"Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors","volume":"33","author":"Terai","year":"1983","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jpain.2005.10.005_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1098-2396(199702)25:2<117::AID-SYN2>3.0.CO;2-F","article-title":"Naloxone-sensitive, haloperidol-sensitive, [3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes","volume":"25","author":"Tsao","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.jpain.2005.10.005_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","article-title":"Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes","volume":"282","author":"Zhu","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590005009259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590005009259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:41:53Z","timestamp":1761507713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590005009259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1526590005009259"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2005.10.005","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroleptics Antagonize Nalbuphine Antianalgesia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2005.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}